25-hydroxycholesterol has been researched along with Pneumonia, Viral in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Q; Cheng, G; Deng, YQ; Gold, S; He, J; Li, J; Li, L; Li, X; Li, XF; Qin, CF; Yang, H; Zhang, C; Zhao, H; Zhou, C; Zu, S | 1 |
1 other study(ies) available for 25-hydroxycholesterol and Pneumonia, Viral
Article | Year |
---|---|
25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor.
Topics: Aged; Angiotensin-Converting Enzyme 2; Animals; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Disease Models, Animal; Fatal Outcome; Female; Humans; Hydroxycholesterols; Mice; Mice, Inbred BALB C; Mice, Transgenic; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Vero Cells; Virus Replication | 2020 |